- Home
- BBGI vs CYCN Comparison
BBGI vs CYCN Comparison
Compare BBGI & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBGI
- CYCN
- Stock Information
- Founded
- BBGI 1961
- CYCN 2018
- Country
- BBGI United States
- CYCN United States
- Employees
- BBGI N/A
- CYCN N/A
- Industry
- BBGI Broadcasting
- CYCN Biotechnology: Pharmaceutical Preparations
- Sector
- BBGI Consumer Discretionary
- CYCN Health Care
- Exchange
- BBGI Nasdaq
- CYCN Nasdaq
- Market Cap
- BBGI 7.6M
- CYCN 8.0M
- IPO Year
- BBGI 2000
- CYCN N/A
- Fundamental
- Price
- BBGI $4.73
- CYCN $2.50
- Analyst Decision
- BBGI
- CYCN
- Analyst Count
- BBGI 0
- CYCN 0
- Target Price
- BBGI N/A
- CYCN N/A
- AVG Volume (30 Days)
- BBGI 5.6K
- CYCN 27.8K
- Earning Date
- BBGI 08-12-2025
- CYCN 08-05-2025
- Dividend Yield
- BBGI N/A
- CYCN N/A
- EPS Growth
- BBGI N/A
- CYCN N/A
- EPS
- BBGI N/A
- CYCN N/A
- Revenue
- BBGI $227,387,784.00
- CYCN $2,174,000.00
- Revenue This Year
- BBGI $5.02
- CYCN N/A
- Revenue Next Year
- BBGI N/A
- CYCN N/A
- P/E Ratio
- BBGI N/A
- CYCN N/A
- Revenue Growth
- BBGI N/A
- CYCN N/A
- 52 Week Low
- BBGI $3.67
- CYCN $1.27
- 52 Week High
- BBGI $14.95
- CYCN $9.47
- Technical
- Relative Strength Index (RSI)
- BBGI 58.10
- CYCN 46.77
- Support Level
- BBGI $4.54
- CYCN $2.41
- Resistance Level
- BBGI $4.79
- CYCN $2.90
- Average True Range (ATR)
- BBGI 0.18
- CYCN 0.22
- MACD
- BBGI 0.01
- CYCN 0.03
- Stochastic Oscillator
- BBGI 71.70
- CYCN 35.48
About BBGI Beasley Broadcast Group Inc.
Beasley Broadcast Group Inc is a multi-platform media company, whose primary business is operating radio stations throughout the United States. The company offers local and national advertisers integrated marketing solutions across audio, digital and event platforms. It owns and operates stations in the following markets: Atlanta, GA, Augusta, GA, Boston, MA, Charlotte, NC, Detroit, MI, Fayetteville, NC, Fort Myers-Naples, FL, Las Vegas, NV, Middlesex, NJ, Monmouth, NJ, Morristown, NJ, Philadelphia, PA, Tampa-Saint Petersburg, FL, and Wilmington, DE. The company operates in two segments Audio and Digital.
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.